Welcome to the Division of Nephrology and the University of Arizona Kidney Disease Program. We are proud that U.S. News & World Report has ranked our program in the top 50 in the country (20182016, 2015) and continues to rate us as high performing for patient care. As the only academic division of nephrology in the state of Arizona, our goal is to provide high quality clinical nephrology care to our patients, to develop innovative and topical research programs that will impact upon the care that we deliver to our patients, and to be a teaching and training resource to our community...

Frank C. "Chip" Brosius, III, MD
Interim Chief, Division of Nephrology

Nephrology

The Division of Nephrology in the University of Arizona Department of Medicine and Banner University Medical Center – Tucson has active programs in clinical nephrology, teaching and training of fellows and residents, and a range of research opportunities. An important focus of the division is to emphasize translational and multi-disciplinary programs that truly go from bedside to bench to bedside in advancing patient care solutions.

At the clinical level, U.S. News & World Report has ranked nephrology care here among the top 50 programs in the country. Division faculty members care for patients with acute kidney injury, glomerulonephritis, complex hypertension, bladder and kidney stones, and chronic kidney disease (CKD). We are one of only four kidney transplant programs in the state of Arizona and have had a recent surge in kidney transplant activity, which has greatly benefitted our community. We also care for an increasing number of patients on hemodialysis, and have a growing home dialysis program (both hemodialysis and peritoneal dialysis) as well. An important and unique strength has been our partnership with Dialysis Clinics Inc. (DCI) to create a nocturnal hemodialysis program.

Faculty members from the Division of Nephrology are also involved in multiple clinical trials (more than 10 trials at present) targeting diverse kidney problems such as chronic kidney disease, kidney transplantation, vascular access dysfunction and glomerulonephritis.

The Division of Nephrology also has vibrant research programs in CKD progression, organ transplantation, renal genomics, dialysis vascular access, device development and tissue engineering.

Last but not least, an important focus of the division is on mentorship. We recognize that our greatest strength is our faculty and fellows. And, while we are committed to growing our clinical and research portfolios, the most important thing that we want to grow and nurture is people—our staff, faculty and fellows!

News & Announcements

Teaser image with Dr. Jennifer Stern on cover of the Journal of Endocrinology
UA-Led Study on Hyperglucagonemia, Type 2 Diabetes Picked Up by Journal of Endocrinology

The Journal of Endocrinology has published a paper with the UA’s Dr. Jennifer Stern as lead author on research that suggests the metabolic glucoregulatory disturbance in obesity that can result in type 2 diabetes may be driven by inappropriate fasting-induced regulation of glucagon, resulting in a static glucagon:insulin ratio…


Teaser image for story on ADA grant to Dr. Dawn Coletta
ADA Awards $600K to Dr. Coletta to Study Mitochondrial Epigenetic Changes in Type 2 Diabetes Patients

Endocrinology’s Dr. Dawn Coletta received a three-year, $600,000 award from the American Diabetes Association (ADA) for a study titled “Unraveling the role of mitochondrial DNA methylation in type 2 diabetes.” With co-investigators Drs. Wayne Willis, Lawrence Mandarino and Janet Funk, this study will determine whether DNA methylation of the mitochondrial DNA impairs mitochondrial function in obese or type 2 diabetes insulin-resistant patients and could lead to therapies to address it…


Teaser image for article on Dr. Daruka Mahadevan being hired by UT Health San Antonio - Mays Cancer Clinic
Dr. Daruka Mahadevan Named Hem-Onc Chief at UT Health San Antonio, Mays Cancer Center

Dr. Daruka Mahadevan, a University of Arizona professor in the Division of Hematology and Oncology, co-leader of the Therapeutic Development Program and director of the Clinical Trials Phase I Program at the UA Cancer Center, was named chief of the Division of Hematology and Medical Oncology at the University of Texas, San Antonio, Department of Medicine and will lead that service line at the Mays Cancer Center at UT Health San Antonio. He’ll start in his new position Dec. 1…


Events

Sep
16
Benzodiazepine Withdrawal Symposium
Conference or Symposium

Sep
25